Literature DB >> 32735972

Prevalence and risk factors for high-frequency basal cell carcinoma in the United States.

Audris Chiang1, Daniel C Solis1, Howard Rogers2, Grace K Sohn1, Hyunje G Cho1, Gillian Saldanha1, David Lapidus3, Shufeng Li1, Kavita Y Sarin1, Jean Y Tang4.   

Abstract

Entities:  

Year:  2020        PMID： 32735972     DOI： 10.1016/j.jaad.2020.07.088

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  1 in total

1.  Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma.

Authors:  James M Kilgour; Aatman Shah; Nicole M Urman; Shaundra Eichstadt; Hanh N Do; Irene Bailey; Amar Mirza; Shufeng Li; Anthony E Oro; Sumaira Z Aasi; Kavita Y Sarin
Journal:  Clin Cancer Res       Date:  2021-08-06       Impact factor: 12.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.